Nov 6, 2025 07:04AM
Nov 6, 2025 07:04AM
Oct 15, 2025 07:00AM
Oct 15, 2025 07:00AM
Sep 25, 2025 07:00AM
Sep 19, 2025 04:39PM
Jun 30, 2025 05:29PM Algernon Announces Amended Terms for Private Placement and Closing of the First Tranche totaling $621,000
May 22, 2025 08:50PM
May 13, 2025 07:00AM
Apr 2, 2025 01:30AM
Aug 2, 2024 07:00AM
Jul 31, 2024 07:00AM
Jul 16, 2024 08:00AM
May 21, 2024 07:00AM Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
Apr 24, 2024 07:47AM
Apr 11, 2024 07:00AM
Mar 27, 2024 12:04PM
Feb 22, 2024 04:16PM
Dec 27, 2023 07:00AM
Dec 12, 2023 07:42PM
Nov 22, 2023 07:00AM Algernon Pharmaceuticals Announces LOI for the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position
Jul 14, 2023 06:00PM
Jun 27, 2023 07:00AM
Apr 20, 2023 07:00AM
Mar 21, 2023 07:00AM
Feb 9, 2023 01:00AM
Jan 11, 2023 07:00AM
Jan 9, 2023 07:00AM Algernon Pharmaceuticals Announces Plans for a 180 Patient Phase 2b Chronic Cough Study of Ifenprodil
Nov 10, 2022 01:30AM
Oct 14, 2022 04:30AM
Aug 11, 2022 01:30AM
May 26, 2022 01:24PM
May 23, 2022 11:47AM
May 23, 2022 11:45AM
May 12, 2022 01:30AM Aegon reports first quarter 2022 results
Feb 23, 2022 07:00AM
Feb 16, 2022 12:20PM
Feb 9, 2022 01:30AM
Nov 24, 2021 07:00AM
Nov 11, 2021 01:30AM
Sep 21, 2021 02:10AM
Sep 21, 2021 02:10AM An update on Aegon's sale of its Central and Eastern European business to VIG
Aug 13, 2021 04:48AM
Aug 13, 2021 04:48AM
Aug 12, 2021 01:30AM
Aug 12, 2021 01:30AM
Aug 11, 2021 07:00AM
Aug 9, 2021 07:00AM
May 12, 2021 01:30AM Aegon reports first quarter 2021 results
May 12, 2021 01:30AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All